Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down 0.06% Nasdaq Down 0.69%
Streaming
Ticker Tape: On

Geron Corporation (GERN)

-NasdaqGS
2.02 Down 0.17(7.76%) 3:19PM EDT - Nasdaq Real Time Price
Get the big picture on all your investments.
Prev Close:2.19
Open:2.17
Bid:2.01 x 19200
Ask:2.02 x 6100
1y Target Est:2.00
Beta:2.46
Earnings Date:Apr 28 - May 2 (Est.)
Day's Range:2.00 - 2.20
52wk Range:1.05 - 7.79
Volume:3,209,479
Avg Vol (3m):6,420,130
Market Cap:316.93M
P/E (ttm):N/A
EPS (ttm):-0.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for GERN

Comparison

Symbol% ChgMkt Cap
GERNDown 7.76%316.93M
BMYUp 0.03%84.17B
GSKDown 0.37%131.98B
NVSDown 0.28%209.41B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):267.82
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.25
Quarterly EPS Est (Mar-14) :-0.06
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):-1.75

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Geron Corporation, a clinical stage biopharmaceutical company, develops a telomerase inhibitor, imetelstat, to treat hematologic myeloid malignancies. The company was founded in 1990 and is based in Menlo Park, California. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback